Ascendis Pharma A/S (ASND)
228.03
+0.16
(+0.07%)
USD |
NASDAQ |
Oct 05, 16:00
228.35
+0.32
(+0.14%)
After-Hours: 20:00
Ascendis Pharma Price : 228.03 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 229.66 | 230.73 | 226.84 | 228.03 | 783227.0 |
| Oct 02, 2026 | 227.63 | 229.02 | 225.20 | 227.87 | 641436.0 |
| Oct 01, 2026 | 228.03 | 229.88 | 226.00 | 227.31 | 805981.0 |
| Sep 30, 2026 | 227.97 | 230.97 | 226.18 | 227.83 | 926230.0 |
| Sep 29, 2026 | 227.42 | 229.89 | 223.70 | 228.07 | 741868.0 |
| Sep 28, 2026 | 226.00 | 231.14 | 224.80 | 230.05 | 747554.0 |
| Sep 25, 2026 | 230.13 | 230.43 | 224.26 | 225.60 | 419975.0 |
| Sep 24, 2026 | 223.00 | 231.13 | 220.23 | 230.70 | 1.166M |
| Sep 23, 2026 | 236.83 | 237.98 | 220.60 | 223.13 | 1.218M |
| Sep 22, 2026 | 239.09 | 240.69 | 234.67 | 237.57 | 548315.0 |
| Sep 21, 2026 | 238.66 | 241.50 | 237.00 | 237.59 | 822985.0 |
| Sep 18, 2026 | 238.15 | 243.68 | 236.02 | 236.72 | 1.559M |
| Sep 17, 2026 | 249.23 | 249.23 | 237.13 | 239.04 | 1.100M |
| Sep 16, 2026 | 239.70 | 249.00 | 237.22 | 247.69 | 1.260M |
| Sep 15, 2026 | 257.17 | 257.53 | 228.56 | 239.77 | 2.961M |
| Sep 14, 2026 | 265.00 | 265.50 | 260.00 | 264.92 | 417846.0 |
| Sep 11, 2026 | 263.34 | 266.34 | 259.48 | 263.52 | 443605.0 |
| Sep 10, 2026 | 260.00 | 262.17 | 258.01 | 261.23 | 505041.0 |
| Sep 09, 2026 | 270.89 | 272.37 | 260.75 | 260.81 | 497435.0 |
| Sep 08, 2026 | 263.41 | 272.47 | 262.32 | 270.09 | 653372.0 |
| Sep 04, 2026 | 267.96 | 271.14 | 265.22 | 270.56 | 723516.0 |
| Sep 03, 2026 | 266.94 | 272.44 | 265.80 | 271.12 | 1.019M |
| Sep 02, 2026 | 261.39 | 268.71 | 257.52 | 267.31 | 418296.0 |
| Sep 01, 2026 | 261.65 | 266.63 | 256.28 | 260.25 | 610604.0 |
| Aug 31, 2026 | 247.65 | 268.98 | 247.65 | 263.04 | 1.026M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| BioMarin Pharmaceutical, Inc. | 57.54 |
| Novo Nordisk A/S | 37.54 |
| Evaxion AS | 3.15 |
| Genmab A/S | 38.48 |
| Zealand Pharma A/S | 40.00 |
Price Related Metrics
| PE Ratio | 17.37 |
| PS Ratio | 11.91 |
| Price to Book Value | 9.118 |
| Price to Free Cash Flow | 37.38 |
| Earnings Yield | 5.76% |
| Market Cap | 14.98B |
| Operating PE Ratio | 115.41 |
| Normalized PE Ratio | 17.37 |